Faeth Therapeutics, Inc. FTH
NASDAQ · United States · Health Technology
$28.35+0.08 (+0.28%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-04 | -2.84 | -2.64 | -7.7% | $0 | — | -10.1%$27.34→$24.59 |
| Q1 2026 | 2026-05-15 | -131.45 | -0.62 | -21,101.6% | — | — | +0.5%$19.82→$19.91 |
| Q4 2025 | 2026-03-30 | -3.74 | -4.81 | +22.2% | — | — | +13.9%$27.68→$31.52 |
| Q3 2025 | 2025-11-14 | -3.62 | -4.11 | +11.9% | — | — | -9.8%$9.02→$8.14 |
| Q4 2024 | 2025-03-28 | -5.46 | -5.80 | +5.9% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.